Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Constantinou

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
South African Journal of Sports Medicine|February 23, 2023
Exploring the efficacy of low-level laser therapy and exercise for knee osteoarthritisA Kholvadia, D Constantinou, P J-L Gradidge
Nucleic Acids Research|August 25, 1990
A sequence polymorphism in the 3'-nontranslated region of the pro alpha 1 chain of type I procollagenA I Westerhausen, C D Constantinou, D J Prockop
South African Journal of Sports Medicine|January 22, 2024
Exercise intervention for post-acute COVID-19 syndrome - do FITT-VP principles apply? A case studyG Torres, N Rains, P J Gradidge, et al.
The Journal of Clinical Investigation|February 1, 1989
A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagenC D Constantinou, K B Nielsen, D J Prockop
Advances in Human Genetics|January 1, 1990
Mutations in type I procollagen genes that cause osteogenesis imperfectaD J Prockop, C T Baldwin, C D Constantinou
American Journal of Medical Genetics|January 15, 1993
Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfectaC D Constantinou-Deltas, R L Ladda, D J Prockop
The Journal of Biological Chemistry|August 25, 1991
Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helixT Tsuneyoshi, A Westerhausen, C D Constantinou, et al.
Autoimmunity|January 1, 1994
Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD miceZ L Zhang, D Constantinou, T E Mandel, et al.
American Journal of Human Genetics|June 1, 1991
A single base mutation in type I procollagen (COL1A1) that converts glycine alpha 1-541 to aspartate in a lethal variant of osteogenesis imperfecta: detection of the mutation with a carbodiimide reaction of DNA heteroduplexes and direct sequencing of products of the PCRJ P Zhuang, C D Constantinou, A Ganguly, et al.
American Journal of Human Genetics|October 1, 1990
Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1)C D Constantinou, M Pack, S B Young, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
South African Journal of Sports Medicine|February 23, 2023
Exploring the efficacy of low-level laser therapy and exercise for knee osteoarthritisA Kholvadia, D Constantinou, P J-L Gradidge
Nucleic Acids Research|August 25, 1990
A sequence polymorphism in the 3'-nontranslated region of the pro alpha 1 chain of type I procollagenA I Westerhausen, C D Constantinou, D J Prockop
South African Journal of Sports Medicine|January 22, 2024
Exercise intervention for post-acute COVID-19 syndrome - do FITT-VP principles apply? A case studyG Torres, N Rains, P J Gradidge, et al.
The Journal of Clinical Investigation|February 1, 1989
A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagenC D Constantinou, K B Nielsen, D J Prockop
Advances in Human Genetics|January 1, 1990
Mutations in type I procollagen genes that cause osteogenesis imperfectaD J Prockop, C T Baldwin, C D Constantinou
American Journal of Medical Genetics|January 15, 1993
Somatic cell mosaicism: another source of phenotypic heterogeneity in nuclear families with osteogenesis imperfectaC D Constantinou-Deltas, R L Ladda, D J Prockop
The Journal of Biological Chemistry|August 25, 1991
Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helixT Tsuneyoshi, A Westerhausen, C D Constantinou, et al.
Autoimmunity|January 1, 1994
Lymphocyte subsets in thymus and peripheral lymphoid tissues of aging and diabetic NOD miceZ L Zhang, D Constantinou, T E Mandel, et al.
American Journal of Human Genetics|June 1, 1991
A single base mutation in type I procollagen (COL1A1) that converts glycine alpha 1-541 to aspartate in a lethal variant of osteogenesis imperfecta: detection of the mutation with a carbodiimide reaction of DNA heteroduplexes and direct sequencing of products of the PCRJ P Zhuang, C D Constantinou, A Ganguly, et al.
American Journal of Human Genetics|October 1, 1990
Phenotypic heterogeneity in osteogenesis imperfecta: the mildly affected mother of a proband with a lethal variant has the same mutation substituting cysteine for alpha 1-glycine 904 in a type I procollagen gene (COL1A1)C D Constantinou, M Pack, S B Young, et al.
Pageof 5